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Addressing the demand for 
termination of pregnancy services 
in district health facilities in 
Johannesburg
To the Editor: The Choice of Termination of Pregnancy (CTOP) 
Act instituted safe, effective, affordable and acceptable methods 
of fertility regulation for women. Universal access to reproductive 
health services is available through the district health services.1
By 2001, there had been a 91% decline in maternal mortality from 
unsafe abortions in South Africa (SA) as a result of the CTOP Act.2 
However, despite the availability of free reproductive health services, 
few women are utilising family planning services in SA.3 Recent 
studies have reported that unsafe abortions are on the increase.4-6
We wished to determine the number of terminations of pregnancy 
(TOPs) requested and the number of TOPs performed from January 
2008 to December 2009 in the Johannesburg Metropolitan District 
(JM). We conducted a descriptive cross-sectional study including 
TOP data from district health information systems in the JM. All 
health facilities offering TOP services at the district level were 
included.
The analyses showed that a total of 14 683 and 16 031 women 
requested TOPs in 2008 and 2009 respectively; these figures might 
have included women in their second trimester, at district facilities. A 
third of requests were performed, with 4 921 and 5 338 first-trimester 
TOPs performed in 2008 and 2009 respectively (Fig. 1). In 2008, a 
total of 6 clinics offered TOP services in the JM. The majority (68%) 
of the first-trimester TOPs were performed by 2 facilities. Two clinics 
which collectively had performed 15% of the total number of TOPs in 
2008, ceased offering TOP services in 2009; only a new clinic initiated 
TOP services in 2009.
Although the number of TOP requests increased from 2008 to 
2009, the facilities offering first-trimester TOP services declined. In 
addition, the number of first-trimester procedures performed was 
far less than the number of requests received. A major concern is 
that if the demand for TOPs remains unmet in the public sector, the 
incidence of unsafe abortions may continue to rise further.
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Medical indemnity regulations: MPS 
maintains commitment to South 
Africa
To the Editor: I want to reassure members of the Medical Protection 
Society and readers of the SAMJ that the surprise new government 
regulations on indemnity will not diminish our longstanding 
and strong commitment to the South African medical and dental 
professions. 
We had no warning of the new regulations and we know their 
publication has caused a great deal of uncertainty, but the regulations 
will not affect MPS members until the end of December and in the 
meantime we are committed to doing everything we can to find a 
long-term solution. 
The MPS has operated in South Africa for over 50 years and we 
want to be here for another 50. We have 25 000 members in South 
Africa, and each of them is important to us. As a mutual, our ethos, 
when looking at whether to offer our services and support in a 
country, is to ask the question: does the profession want us? We 
have been overwhelmed by the support we have received from our 
members over the past week, and this has galvanised our search 
for a solution that will allow the MPS to continue to indemnify and 
support doctors and dentists in South Africa. We are also encouraged 
by the response of government agencies and regulators who have 
voiced a strong desire for us to remain.
We do not dispute the principle behind the regulations; we agree 
that medical professionals should have compulsory professional 
indemnity so that they and their patients are protected if something 
avoidable goes wrong. We also support the requirement that 
indemnifiers should be capable of regulation. Our objection – our 
strong objection – is the preclusion of the indemnity that the MPS 
provides, which is widely regarded as the best available. Although 
it is discretionary, it allows us the flexibility to provide help and 
support in circumstances where a claim may otherwise be rejected 
by an insurer. In our long history there has been no case of the MPS 
declining to meet a proven claim of negligence that has resulted in 
a patient being left uncompensated. The occurrence-based nature 
Fig. 1. Distribution of number of TOP requests and first trimester TOP pro-
cedures performed per month from January 2008 to December 2009 in the 
Johannesburg Metropolitan District.
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of MPS indemnity means that doctors only need to be a member of 
the MPS at the time something goes wrong; after that, assistance can 
be requested at any time even if the doctor has moved away, taken a 
career break or retired. This provides comfort and peace of mind for 
the doctor and his or her patients. 
In contrast, insurance contracts are complex and are governed by 
the wording of the policy conditions. They also are invariably based 
on the ‘claims made’ principle, which means that cover ceases at the 
end of the policy unless the individual doctor purchases ‘run-off ’ 
cover to meet past incidents that have yet to be reported as claims. It 
is because we so firmly believe in providing our members with what 
is best for them and their patients that we remain so committed to 
our discretionary occurrence-based model of indemnity.
I want to emphasise that the MPS is far more than a provider of 
professional indemnity against claims of negligence. We also assist 
with any problem that arises from a doctor or dentist’s professional 
practice. This might include advice on ethical issues or support with 
disciplinary proceedings, inquests or medical council inquiries.  
One of the core benefits of membership is our confidential 
counselling service, which we fund because the pressures facing those 
working within health care are such that the consequences of even 
the smallest error can be personally devastating for the individual 
doctor.
The MPS has accumulated a vast wealth of experience and 
expertise in medico-legal issues over many years and from more 
than 30 countries – we are truly world experts in our field. The 
MPS is committed to help improve patient safety, and we share our 
expertise to help prevent future problems occurring. We do this 
through lectures, seminars, courses and workshops. For doctors 
our influential publications such as Casebook and Junior Doctor are 
core components of continuing education, and we regularly develop 
materials on important matters such as consent and risk management 
issues.  
We have evolved over the many years we have been in South 
Africa and, with the support of members and the profession, we 
want to evolve further in the future. We hope you will support our 
campaign to persuade the Minister of Health to review the new 
regulations and to allow us to continue to provide a high-quality 
service to our members and their patients. As our attempts to secure 
a solution progress, we will update you on progress regularly via the 
MPS website. No one should be in any doubt of the intensity of our 
activity to find a solution that is acceptable to the profession and to 
government.
South Africa is and will remain of immense importance to the 
MPS. 
A D Mason
Chief Executive
Medical Protection Society
UK
tony.mason@mps.org.uk
Solubility tests and the peripheral 
blood method for screening for sickle-
cell disease
To the Editor: We refer to the paper by Okwi et al.1 Cost benefit 
analysis of screening for sickle cell disease (SCD) using different 
methods cannot be done in isolation, and the following are important 
principles to take into account.
1.    Reasons for screening: (i) early detection of the disease for timely 
intervention to minimise morbidity and mortality; (ii) patient 
and family education on SCD; (iii) genetic counselling as part of 
a long-term strategy to prevent live homozygous SCD (SS) births; 
and (iv) short- and long-term cost saving by means of (i), (ii) and 
(iii) above.
2.    The method of detection needs to be very sensitive. Subjects 
with false-negative results will remain undiagnosed and may well 
present with an acute crisis or organ damage, with major cost 
implications.
The sensitivities of the sickling and solubility tests for detection 
of the sickle cell trait (AS) as reported by the authors were 65% and 
45%, respectively, essentially translating to high 35% and 65% false-
negative rates, an unacceptable scenario regardless of cost saving. 
Clearly the methodologies need to be questioned, since the 
sickling test is sensitive enough to detect AS.1,2 In addition, the article 
advocates that negative sickling tests be regarded as negative for the 
disease, evidently with no further testing required. This means that 
35% of the subjects tested will walk around with undiagnosed AS 
despite having been tested, which defeats the objectives of screening 
as stated above.
The recommendation by the group that the sickling test be the 
preferred and sole method for screening, purely on the basis of 
economics, is disconcerting, while with its observed shortcomings 
the proposed screening method would be of short-term benefit.
We conclude that a cost benefit analysis of methods with such low 
sensitivities is ineffective and futile. 
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Okwi et al. reply: Our cost benefit analysis was not done in isolation, 
as suggested above. The paper was published together with others 
that appeared elsewhere and addressed the issues raised. Sensitisation 
of communities (patient and family education on SCD) and timely 
intervention were covered in a publication in the East African 
Medical Journal.1 Another paper addressing some of these issues was 
published in BMC Blood Disorders.2
All the false negatives with the sickling test were cases of AS 
(carriers), not SS. The sickling test demonstrated all SS cases, as did 
Hb electrophoresis – i.e. sickling was sensitive in SS detection but not 
in AS detection. The sickling test would therefore be sensitive enough 
to detect all the children with SS, who would benefit most since they 
suffer from crisis, while carriers (AS) do not. 
Lastly, the authors state that our article advocated interpreting a 
negative sickling test as the patient being negative for the disease, 
with no further testing required. We did not assume or recommend 
this. Our assumption was that all the children who might accidentally 
be missed by the sickling test and develop symptoms later would be 
tested by Hb electrophoresis.
